Brent Mc Henry
About Brent Mc Henry
Brent Mc Henry is the Director of Biostatistics at BeiGene and Bristol Myers Squibb, with over 15 years of experience in the pharmaceutical industry.
Current Roles at BeiGene and Bristol Myers Squibb
Brent Mc Henry currently serves as the Director of Biostatistics at both BeiGene and Bristol Myers Squibb. In these roles, he applies his extensive expertise in biostatistics to oversee and manage statistical methodologies and analyses in various clinical trials, particularly focusing on oncology. His responsibilities also include contributing to the development of statistical analysis plans and supporting regulatory submissions to health authorities such as the FDA and EMA.
Professional Experience at Bristol Myers Squibb
Brent Mc Henry has held several positions at Bristol Myers Squibb over a span of more than 15 years. His tenure began as a Research Biostatistician from 2005 to 2006. He then ascended to roles including Senior Biostatistician, Principal Statistician, and eventually Associate Director of Biostatistics. From 2017 to 2021, he served as Senior Associate Director before becoming Director of Biostatistics. During this period, he worked remotely from Charleston, SC, as well as in New Jersey, contributing significantly to various statistical projects, especially in clinical trials.
Educational Background
Brent Mc Henry studied at the University of Pittsburgh, where he earned his Doctor of Philosophy (PhD) in Biostatistics. He completed his doctoral studies in 2003, laying a strong foundation for his future career in biostatistics and statistical methodologies. His academic background equips him with a deep understanding of statistical theory and practical analysis techniques.
Contributions to Biostatistics and Clinical Trials
Throughout his career, Brent Mc Henry has contributed extensively to the field of biostatistics, especially within the context of clinical trials. He has expertise in statistical methodologies for oncology trials and has played a significant role in developing statistical analysis plans for high-profile drug submissions. He has been an active participant in cross-functional teams, supporting regulatory submissions to both the FDA and EMA.
Academic and Professional Engagement
Brent Mc Henry has published several peer-reviewed articles in the realms of biostatistics and clinical trial methodology. He has also presented his research findings at major conferences. Additionally, he has been actively involved in mentoring junior biostatisticians and providing training on advanced statistical techniques. His professional engagement extends to his active involvement in organizations such as the American Statistical Association, where he contributes to the broader statistical community.